Guardian Pharmacy Services, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 |
|---|---|---|---|
| Income Statement | |||
| Revenue | $1.4B | $1.2B | — |
| Cost of revenue | $1.2B | $984.0M | — |
| Gross profit | $292.7M | $244.4M | — |
| Selling, general & administrative | $220.0M | $307.3M | — |
| Operating income | $72.7M | -$62.9M | — |
| Interest expense | $665,000 | $3.3M | — |
| Pretax income | $73.4M | -$66.5M | — |
| Income tax expense | $24.5M | $4.6M | — |
| Net income | $49.2M | -$110.0M | — |
| Balance Sheet | |||
| Cash and equivalents | $65.6M | $4.7M | — |
| Current assets | $221.6M | $152.0M | — |
| Total assets | $412.7M | $320.8M | — |
| Current liabilities | $160.7M | $144.1M | — |
| Total liabilities | $194.7M | $170.8M | — |
| Stockholders' equity | $217.9M | $150.0M | $59.9M |
| Cash Flow Statement | |||
| Cash from operations | $100.3M | $58.0M | — |
| Depreciation and amortization | $22.3M | $19.8M | — |
| Stock-based compensation | $13.8M | $131.5M | — |
| Capital expenditure | $13.4M | $14.7M | — |
| Free cash flow | $86.8M | $43.2M | — |
| Impairments | $0 | — | — |
Shares outstanding 63.3M · Free float 26.3%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.